argenx SE (STU:1AE)
€ 553.6 6 (1.1%) Market Cap: 33.43 Bil Enterprise Value: 30.56 Bil PE Ratio: 0 PB Ratio: 8.44 GF Score: 82/100

argenx SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 05:00PM GMT
Release Date Price: €137.6 (+0.81%)
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

Good afternoon. Thanks, everybody, for joining us at the now virtual Bank of America Health Care Conference. I'm Tazeen Ahmad. I am one of the senior SMid biotech analysts here at the firm. It's my pleasure to have our next presenting company with me, argenx. Presenting from argenx this afternoon will be Chief Executive Officer, Tim Van Hauwermeiren; as well as Chief Operating Officer, Keith Woods.

Tim and Keith, good afternoon. Thanks very much for joining us today.

Tim Van Hauwermeiren
argenx SE - CEO & Executive Director

Hi, Tazeen. Thanks for hosting us.

R. Keith Woods
argenx SE - COO

Thanks for having us here today.

Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

So I think this will be a good use of the next 30 minutes. Maybe, Tim, can you, for anyone on the line who may not know your story as well, give us just a couple of minute overview of argenx, about just the company, what your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot